摘要:
Described are arithmetic circuits divided logically into a product generator and an adder. Multiplexing circuitry logically disposed between the product generator and the adder supports conventional functionality by providing partial products from the product generator to addend terminals of the adder. The multiplexing circuitry can also be controlled to direct a number of external added inputs to the adder. The additional addend inputs can include inputs and outputs cascaded from other arithmetic circuits.
摘要:
Described are mathematical circuits that perform flexible rounding schemes. The circuits require few additional resources and can be adjusted dynamically to change the number of bits involved in the rounding. In one embodiment, a DSP circuit stores a rounding constant selected from the group of binary numbers 2(M−1) and 2(M−1)−1, calculates a correction factor, and sums the rounding constant, the correction factor, and a data item to obtain a rounded data item.
摘要:
A digital clock manager having differential clock signal paths is provided. The differential clock signal paths are provided by replacing single-ended circuit elements of a conventional digital clock manager with symmetrical cascade voltage switch logic (CVSL) circuit elements, including CVSL delay buffers, CVSL multiplexers, CVSL AND gates, CVSL OR gates and CVSL set-reset latches. These symmetrical CVSL AND gates, CVSL OR gates and CVSL set-reset latches represent new circuit elements.
摘要:
Structures and methods of including processor capabilities in an existing PLD architecture with minimal disruption to the existing general interconnect structure. In a PLD including a column of block RAM (BRAM) blocks, the BRAM blocks are modified to create specialized logic blocks including a RAM, a processor, and a dedicated interface coupled between the RAM, the processor, and the general interconnect structure of the PLD. The additional area is obtained by increasing the width of the column of BRAM blocks. Because the interconnect structure remains virtually unchanged, the interconnections between the specialized logic blocks and the adjacent tiles are already in place, and the modifications do not affect the PLD routing software. In some embodiments, the processor can be optionally disabled, becoming transparent to the user. Other embodiments provide methods of modifying a PLD to include the structures and provide the capabilities described above.
摘要:
A PLD can be manufactured to include power supply lines from two sources so that a portion of the PLD can be backed up with a battery when power to the PLD is removed. A switch that supplies power to the backed up portion of the PLD receives power from both an external power supply and from the battery, and detects voltage level of the external power supply, switching to battery power when voltage from the external power supply is not sufficient.
摘要:
A programmable logic device (PLD) comprises at least one configurable element, and a plurality of programmable logic elements for configuring the configurable element(s). Alternatively, a PLD comprises an interconnect structure and a plurality of programmable logic elements for configuring the interconnect structure. In either embodiment, at least one of the programmable logic elements includes N memory cells. A predetermined one of the N memory cells forms part of a memory slice, wherein at least a portion of each slice of the programmable logic device is allocated to either configuration data or user data memory. Typically, one memory slice provides one configuration of the programmable logic device. In accordance with one embodiment, a memory access port is coupled between at least one of the N memory cells and either one configurable element or the interconnect, thereby facilitating loading of new configuration data into other memory slices during the one configuration. The new configuration data may include off-chip or on-chip data. The present invention typically allocates at least one slice to user data memory and includes means for disabling access to at least one of the N memory cells.
摘要:
Antibody/signal-generating moiety conjugates are disclosed that include an antibody covalently linked to a signal-generating moiety through a heterobifunctional polyalkyleneglycol linker. The disclosed conjugates show exceptional signal-generation in immunohistochemical and in situ hybridization assays on tissue sections and cytology samples. In one embodiment, enzyme-metallographic detection of nucleic acid sequences with hapten-labeled probes can be accomplished using the disclosed conjugates as a primary antibody without amplification.
摘要:
An Integrated Circuit (IC) having a single-instruction-multiple-data (SIMD) is disclosed. The SIMD circuit includes: a plurality of multiplexers controlled by a first opcode; and an arithmetic logic unit (ALU) coupled to the plurality of multiplexers and controlled by a second opcode; and wherein the ALU has a plurality of adders, where the plurality of adders are controlled by some bits of the second opcode, and where a first adder of the plurality of adders adds a plurality of input bits to produce first summation bits and a first carry bit; the first adder operating concurrently with the other adders of the plurality of adders.
摘要:
An integrated circuit that includes a digital signal processing element (DSPE) having a first and a second register block coupled to a first arithmetic logic unit (ALU) circuit; a middle DSPE adjacent to the top DSPE having a third and a fourth register block coupled to a second ALU circuit, where the third register block is coupled to the first register block, and the fourth register block register block is coupled to the second register block; and a bottom DSPE adjacent to the middle DSPE having a fifth and a sixth register block coupled to a third ALU circuit, where the fifth register block is coupled to the third register block and the sixth register block register block is coupled to the fourth register block.
摘要:
Described herein are methods and medical devices used to deliver bioactive agents locally to patients in need of treatment and/or prevention of cardiovascular conditions Local delivery of protease-activated receptor 1 (PAR-1) antagonists are described herein from implantable medical devices including, but not limited to, stents.